Evidence map›Paper›PMID 41744866›Full record

ArticleCurrent oncology (Toronto, Ont.)2026

People Living with HIV Eligibility in Canadian Cancer Clinical Trials.

Maria F Comelles, Santiago Perez-Patrigeon, Tessa Senneker, Anna Johnson, Lisa K Hicks, Lynda Balneaves, Bingshu E Chen, Annette E Hay

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current oncology (Toronto, Ont.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Maria F ComellesCanadian Cancer Trials Group, Queen's University, Kingston, ON K7L 3N6, Canada.
Santiago Perez-PatrigeonKingston General Hospital, Kingston Health Sciences Centre, Queen's University, Kingston, ON K7L 2V7, Canada.ORCID 0000-0002-5912-453X
Tessa SennekerKingston General Hospital, Kingston Health Sciences Centre, Queen's University, Kingston, ON K7L 2V7, Canada.ORCID 0009-0006-6275-5988
Anna JohnsonCanadian Cancer Trials Group, Queen's University, Kingston, ON K7L 3N6, Canada.
Lisa K HicksDivision of Hematology, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Toronto, ON M5B 1W8, Canada.
Lynda BalneavesCollege of Nursing, University of Manitoba, Winnipeg, MB R3T 2N2, Canada.ORCID 0000-0002-6535-2096
Bingshu E ChenCanadian Cancer Trials Group, Queen's University, Kingston, ON K7L 3N6, Canada.ORCID 0000-0001-6139-0696
Annette E HayCanadian Cancer Trials Group, Queen's University, Kingston, ON K7L 3N6, Canada.ORCID 0000-0003-4581-3390

Funding

Queen's University 6041978
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Clinical Trials as TopicEligibility DeterminationHIV InfectionsNeoplasmsPatient SelectionCanadaCross-Sectional StudiesHumansclinical trials as a topiceligibility determinationhealth equityHIV Infectionsmedical oncology

Identifiers

PMID41744866
PMCPMC12940078

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.